Brexpiprazole dihydrochloride
Names
[ CAS No. ]:
913612-38-1
[ Name ]:
Brexpiprazole dihydrochloride
Biological Activity
[Description]:
Brexpiprazole (OPC-34712) hydrochloride, an atypical orally active antipsychotic drug, is a partial agonist of human 5-HT1A and dopamine D2L receptor with Kis of 0.12 nM and 0.3 nM, respectively. Brexpiprazole hydrochloride is also a 5-HT2A receptor antagonist with a Ki of 0.47 nM. Brexpiprazole hydrochloride also shows potent antagonist activity at human noradrenergic α1B (Ki=0.17 nM) and α2C receptors (Ki=0.59 nM)[1][2].
[Related Catalog]:
[Target]
5-HT1A Receptor:0.12 nM (Ki)
5-HT2A Receptor:0.47 nM (Ki)
D2L Receptor:0.3 nM (Ki)
human noradrenergic α1B:0.17 nM (Ki)
human noradrenergic α2C:0.59 nM (Ki)
[In Vitro]
Brexpiprazole (0-1.0 μM, 4 days) potentiates NGF-induced neurite outgrowth in a dose-dependent manner in PC12 cells[1].
[In Vivo]
Brexpiprazole (0-0.1 mg/kg; p.o.; once) improves social recognition deficits in mice[2]. Animal Model: Male C57BL/6NCrSlc mice, Dizocilpine (0.1 mg/kg) (HY-15084B) induced social recognition deficits[2] Dosage: 0.01, 0.03 and 0.1 mg/kg Administration: Oral administration, once Result: Significantly ameliorated Dizocilpine-induced social recognition deficits, without sedation or a reduction of exploratory behavior.
[References]
Chemical & Physical Properties
No Any Chemical & Physical Properties
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.